Abstract
Introduction
NKG2D is an activating receptor expressed on natural killer (NK) cells, CD8 + T, cd T and NKT cells as well as on activated macrophages. Ligands of human NKG2D include MHC class I chain-related protein A/B (MICA/MICB) and UL16-binding proteins (ULBPs). Mouse NKG2D ligands include retinoic acid early induced transcript-1 (RAE-1a, RAE1b, RAE-1c, RAE-1d, RAE-1e), H60 and murine ULBP-like transcript 1 (MULT-1) [1, 2] . NKG2D ligation can stimulate NK cells and costimulate CD8 + T cells. NKG2D in association with its adaptor molecules, namely DAP10 or DAP12, transduces signalling by the activation of phosphatidylinositol 3-kinase (PI3K), resulting in cell activation, survival, cytoskeletal rearrangement and release of cytokines and cytotoxic granules [3, 4] .
CD4
+ NKG2D + T cells are associated with inflammatory diseases, such as rheumatoid arthritis (RA) [5, 6] , granulomatosis with polyangiitis [7] , Crohn's disease [8] [9] [10] , multiple sclerosis [11] and infection by human cytomegalovirus (CMV) [12] . Patients with cervical intraepithelial neoplasia grade 1 [13, 14] , colon cancer [15] and melanoma who were pre-treated with a multityrosine kinase inhibitor (sorafenib) also exhibit enhanced frequencies of CD4 + NKG2D + T cells [16] . These CD4 + NK2D + T cells exhibit Th1-like properties in tissues because of the produced IFN-c, TNF-a and cytolytic granules. IL-15 of the microenvironment either in cis or in trans form contributes to the induction of CD4 + NKG2D + T cell subset [5, 7, 16] . CD4 + NKG2D + T cell population, which is associated in regulatory activities, is normally found in healthy individuals; CD4 + NKG2D + T cell population is inversely correlated with disease severity in patients with juvenile-onset systemic lupus, suggesting that CD4 + NKG2D + T cells acts in regulation rather than inflammation [17] . Furthermore, studies of patients with different malignancies indicated that a large proportion of CD4 + NKG2D + T cells with regulatory activity is largely dependent on FasL and TGF-b; hence, this T cell subset features an immunosuppressive property [18] .
The number of mouse CD4 + NKG2D + T cell population significantly increased in RAE-1e transgenic mice, whose RAE-1e expression was controlled by the CD86 promoter. CD4 + NKG2D + T cells produced TGFb to down-regulate NKG2D expression on NK cells, whereas Foxp3 was not expressed in the cytoplasm [19] 
Materials and methods

Reagents and mice
The following antibodies were obtained from Biolegend (San Diego, CA) or eBioscience (San Diego, CA): CD3 (17A2), cd (GL3), CD8 (53.67), CD4 (GK1.5), NK1.1 (PK136), NKG2D (CX5), CD107a (1D4B), IFN-c (XMG1.2), NKp46 (29A1.4), NKG2A (16A11), Ly49D (4E5), Ly49H (3D10), TGF-b (TW7-16B4), FasL (MFL3), IL-10 (JES5-16E3), IL-17 (eBio17B7), CD62L (MEL-14), CD44 (IM7), granzyme B (NG2B), perforin (eBioOMAK-D), CD25 (PC61.5), Foxp3 (FJK-16S), GITR (YGITR 765), CTLA-4 (UC10-4B9), CD39 (24DMS1), CD69 (LG.3A10), CCR9 (CW-1.2), CD28 (E18), T-bet (4B10), GATA-3 (16E10A23) and ROR-ct (AFKJS-9), neutralized TGF-b antibody (1D11) and RAE-1e mAb (205001). C57BL/6 and pCD86-RAE-1 transgenic mice [19] were generated and housed in accordance with the rules of Animal Committee of Yangzhou University.
Induction and evaluation of acute colitis in mice
Colitis was induced by administration of DSS (2.5% w/v; m.w., 36-50 kD; MP Biomedicals, Santa Ana, CA, USA) to drinking water for 7 days (n = 5). All mice were weighed every day. To assess the extent of colitis, loss in bodyweight (0, none; 1, 1% to 5%; 2, 5% to 10%; 3, 10% to 20%; and 4, >20%), stool consistency (0, normal; 2, loose stools; and 4, watery diarrhoea) and blood in the stool (0, normal; 2, slight bleeding; and 4, gross bleeding) were monitored daily by trained individuals blinded to the treatment groups. Disease activity scores are calculated using the total score, which ranged from 0 to 12. The mice were killed on day 8, and the spleens and intestinal tissues were removed for ex vivo analysis. All experimental protocols were approved by the Institutional Animal Care and Use Committee of Yangzhou University.
Isolation of colonic lymphocytes
Colon tissues of experimental mice were collected and washed completely with cold phosphate-buffered saline (PBS). The tissues were dissected longitudinally, washed completely and cut into smaller pieces. The tissues were then predigested by Hanks' balanced salt solution (HBSS) with 5 mM EDTA and 1 mM DTT at 37°C for 20 min. Mixed cell solution was passed through a nylon filter (100 lm) and then digested in PBS containing collagenase D (0.5 g/L), DNase I (0.5 g/L) and dispase II (3 g/L) for another 20 min. The cell suspension was centrifuged, suspended and washed with RPMI 1640 three times. The mixed cells were supplemented with 35% Percoll and then centrifuged to isolate mononuclear cells. Finally, the mononuclear cells were washed with PBS for further study.
Flow cytometric intracellular staining
Cytokine production was determined using an intracellular staining kit (eBioscience). Lymphocytes were cultured with PMA (200 ng/ml)/ionomycin (2 lg/ml) in the presence of brefeldin A (10 lg/ml) for 4 hrs at 37°C. At the end of the incubation period, the cells were prestained with antibody against surface markers. The cells were fixed, permeabilized, stained with cytokine or isotype antibody and analysed by flow cytometry. Lymphocytes were also permeabilized in referenced buffer and incubated with antibodies against Foxp3, T-bet, GATA-3 or ROR-ct.
Immunofluorescence
Mouse tissues were embedded in OCT and frozen instantly in liquid nitrogen for cryostat sections. After fixation, the sections were blocked with donkey serum and stained with goat antimouse RAE-1e antibody (AF1136; R&D systems, Minneapolis, MN, USA). The sections were washed and stained with Alexa-546 labelled donkey anti-goat as secondary antibody. The sections were covered with DAPI (Vector Labs, Burlingame, CA, USA). Fluorescence was detected using Eclipse E600 (Nikon, Japan) microscope and analysed using NIS-Elements software (Nikon, Japan).
Adoptive transfer of lymphocytes
Splenic NK1.1 À CD4 + cells from pCD86-RAE-1 transgenic mice were negatively isolated using a CD4 + T cell isolation kit. The cells were stained with PE-antimouse NKG2D antibody and magnetic-labelled anti-PE antibody sequentially. The sorted CD4 + NKG2D + T cells (5 9 10 5 ) were injected into the tail vein of DSS-or PBS-treated mice (n = 5) on days 1, 3 and 5. On day 7, the mice were killed to obtain mononuclear colon cells and spleens. Frequencies of CD4 + NKG2D + T cells were analysed using flow cytometry gated on 7-AAD À CD45 + NK1.1 À cells. (Fig. 1A) , whereas CD4 + NKG2D + cells increased in the spleen of DSS-treated mice (Fig. 1B) . The absolute number of CD4 + NKG2D
RNA profile analysis
+ cells also decreased in the colons of DSS-treated mice (Fig. 1A ).
More than 80% of CD4 + NKG2D + T cells did not express NK1.1, which is an NK cell marker (Fig. 1C) . However, the frequency of total CD4 + T cells was enhanced in the colons but decreased in the spleens of DSS-treated mice compared with those in PBS-treated mice (Supplementary Fig. 1A Fig. 3 ). Delayed onset of DSS-induced colitis was observed in the pCD86-RAE-1 transgenic mice, in which numerous CD4 + NKG2D + T cells were induced [19] . After DSS treatment, we checked the frequencies of NK1.1 À CD4 + NKG2D + cells in the colon of transgenic and wild mice. Compared with that in PBS treatment, the frequency of NK1.1 À
CD4
+ NKG2D + cells in the colon decreased in transgenic DSS-treated mice. However, the frequency of NK1.1 À CD4 + NKG2D + cells in the colon of transgenic DSS-treated mice remained higher than those in wild-type DSS-treated mice (Fig. 1E) . The frequency of NK1.1 À CD4 + NKG2D + cells in the spleen of transgenic DSS-treated mice was also enhanced ( Supplementary Fig. 4) .
RAE-1 expression in colon tissues was observed using an immunofluorescence technique to investigate whether the RAE-1 expression level of intestinal epithelium is correlated with the infiltration of NK1.1 À CD4 + NKG2D + cells into the colon. RAE-1 expression level decreased in the colon epithelium of wild-type DSS-treated mice but was maintained in the colons of transgenic DSS-treated mice (Fig. 1F,G (Fig. 3A,B) . Some regulatory T cells also express membrane-bound TGF-b [20] . Membrane TGF-b expression on fresh NK1.1 À CD4 + NKG2D + cells of spleens from DSS-or PBS-treated mice was confirmed by flow cytometric analysis without cell permeabilization (Supplementary Fig. 6 ). When NK1. (Fig. 3C) . TGF-b blocking almost diminished the protective effect (Fig. 3C) . In addition, the colon sections of mice transfused with NK1. (Fig. 3D) significant variations in NK1.1 À CD4 + NKG2D + cell frequency were detected in the spleen of DSS-treated mice with or without the transfer of NK1.1 À CD4 + NKG2D + cells (Fig. 3E ). In addition, colonic NK1.1 À CD4 + NKG2D + cells also highly expressed TGF-b, as confirmed in Fig. 3F + T subpopulation of spleens from both DSS-treated and control mice did not express CD25, Foxp3, GITR, CD223 (LAG-3) and CTLA-4, but expressed CD39 at low levels (Fig. 4A) . These cell markers are regarded as Treg-associated molecules ( Supplementary  Fig. 7 ) [21, 22] . NK1.1 À CD4 + NKG2D + T cells moderately expressed CD69 and chemotactic receptor CCR9 (Fig. 4B) , indicating that these cells exhibit potential to migrate into the intestine. Several studies show that CD4 + NKG2D + T cells with CD28 negative expression have autoreactivity and promote local inflammation [23, 24] . In the present study, NK1. (Fig. 6D ). In addition, NK1.1 À CD4 + NKG2D + T cells expressed low levels of GATA-3 in the cytoplasm, and NK1.1 + CD4 + NKG2D + T cells showed enhanced expression of GATA-3 (Fig. 6E) . Thus, NK1.1 À CD4 + NKG2D + T cells could not differentiate into Th2 and Th17 cells. The subset performed regulatory functions with expression of T-bet.
Discussion
In this work, we divided CD4 + NKG2D + T cells into two subsets based on NK1.1 expression. Colonic NK1. [17, 18] . Molecular mechanisms of TGF-b production by NK1.1 À CD4 + NKG2D + cell after coligation of TCR and NKG2D are still being studied.
The pro-inflammatory role of CD4 + NKG2D + T cells was observed in patients with rheumatoid arthritis [5, 6] , multiple sclerosis [11] , Crohn's disease [8] [9] [10] , granulomatosis with polyangiitis [7] and CMV infection [12] . In addition, CD4 + NKG2D + T cells were negative in grade 1 cervical intraepithelial neoplasia and melanoma patients treated with sorafenib [16] . CD161, a homolog of mouse NK1.1, is expressed on CD4 + NKG2D + T cells of patients with Crohn's disease. Th17 and Th1 represent 30% AE 17% and 12% AE 5%, respectively, of the lamina propria CD4 + NKG2D + population [9] . In the present study, NK1. [32] and moderate levels of CD69 [33] and CCR9 [34] , suggesting that NK1.1 À CD4 + NKG2D + T cells exhibit potential to migrate into colon tissues. The retention of NK1.1 À CD4 + NKG2D + T cells in spleens partly resulted from the enhanced expression level of NKG2D ligands of splenic macrophages or DCs under the DSSinduced inflammatory situations. Macrophages or DCs would up-regulate NKG2D ligand expression when they are stimulated by Toll-like receptor ligand [35] or IFN-a [36] .The expression of the NKG2D ligand in islets is sufficient to recruit CTLs, regardless of their antigen specificity [37] . RAE-1 in colon epithelium also affected the recruitment of NK1.1 À CD4 + NKG2D + T cells, because pCD86-RAE-1 transgenic mice showed higher expression levels of RAE-1 in the colons after DSS treatment than those of the wild mice.
In 
Disclosures
All authors have declared there are no financial conflicts of interest with regard to this work.
Supporting information
Additional Supporting Information may be found online in the supporting information tab for this article: 
